Appendiceal Cancer
Appendiceal Cancer
Explore linked clinical trials. Standard reference: MESH:M03321178 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies | Abdominal Neoplasms, Adnexal Diseases, Appendiceal Cancer, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Necrosis, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Urogenital Diseases, Urogenital Neoplasms, appendiceal neoplasm, cecal disorder, cecal neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneal mesothelioma, peritoneal neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-10-08 | NCT04847063 | |
| A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colorectal adenocarcinoma, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Not applicable | 2026-07-21 | NCT07291180 | |
| Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | Appendiceal Cancer, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Extrahepatic Cholangiocarcinoma, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, biliary tract disorder, carcinoma, cecal disorder, cecal neoplasm, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, intestinal disorder, intrahepatic cholangiocarcinoma, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-07-02 | NCT06101277 | |
| Molecular Profiling for Risk Stratification in Appendiceal Cancer | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, appendix adenocarcinoma, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm | Recruiting | Not stated | 2026-06-29 | NCT07587268 | |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-16 | NCT05194995 | |
| Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) | Appendiceal Cancer, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, intestinal disorder, neoplasm, stomach disorder | Recruiting | Phase 4 | 2025-09-15 | NCT07124351 | |
| Genetics of Appendix Cancer Study | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, appendiceal neoplasm, appendix adenocarcinoma, appendix neuroendocrine tumor G1, carcinoma, cecal disorder, cecal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, neuroendocrine tumor of the appendix, well differentiated, low or intermediate grade | Recruiting | Not stated | 2025-04-18 | NCT05734430 | |
| Molecular Characterisation of Appendiceal Cancer | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Not stated | 2025-01-01 | NCT05364788 |